Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Human papillomavirus (HPV) vaccinations are now recorded on the Australian Immunisation Register (AIR). This makes it easier for you and your healthcare provider to find information about your or your child’s HPV vaccinations.
Transcript of the Chief Medical Officer, Professor Brendan Murphy's interview on ABC Brisbane with Craig Zonca and Rebecca Livingstone regarding drinking water.
Transcript of the Chief Medical Officer, Professor Brendan Murphy's interview on ABC Perth with Tim McMillan and Nadia Mitsopoulos regarding drinking water.
The Community should be reassured that our drinking water is safe.
November is Lung Cancer Awareness Month and from 1 November, Keytruda® will be listed on the PBS for first-line treatment of people with metastatic non-small cell lung cancer.
The Australian Government will invest $52 million to protect Australian teenagers against meningococcal through a free national program for 14 to 19 year olds.
More than 400,000 Australians will now be able to access lifesaving scans for cancer, stroke, heart and other medical conditions with a $175 million investment from the Australian Government.
The Australian Government will invest $1 million from the Medical Research Future Fund to extend a rare cancers clinical trial.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
Coverage rates amongst Australian children continue to improve with 5 year old children having the highest coverage rates in history. 94% of Australian 5 year olds and over 96% of Aboriginal and Torres Strait Islander 5 year olds are now fully vaccinated.
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.
Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.
Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).